Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Hainaut

Showing results (101-110 of 280) with videos related to

Pageof 28
Sort By:
The Journal of Gene Medicine|March 9, 2005
Poor intercellular transport and absence of enhanced antiproliferative activity after non-viral gene transfer of VP22-P53 or P53-VP22 fusions into p53 null cell lines in vitro or in vivoDavid Zavaglia, Erh-Hsuan Lin, Mélanie Guidetti, et al.
IARC Scientific Publications|September 25, 2012
Future perspectives on molecular epidemiologyMartyn T Smith, Pierre Hainaut, Frederica Perera, et al.
Mutation Research|May 10, 2005
TP53 mutations as biomarkers for cancer epidemiology in Latin America: current knowledge and perspectivesClaudia Vitória de Moura Gallo, Gulnar Azevedo E Silva Mendonça, Emanuela de Moraes, et al.
Orphanet Journal of Rare Diseases|April 30, 2014
The profile and contribution of rare germline copy number variants to cancer risk in Li-Fraumeni patients negative for TP53 mutationsAmanda G Silva, Ana C V Krepischi, Peter L Pearson, et al.
Cancer Research|May 23, 2002
Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation: evidence for a precursor lesionGiulia Fulci, Nobuaki Ishii, Daniela Maurici, et al.
Oncogene|October 3, 2002
DeltaN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53Stéphanie Courtois, Gerald Verhaegh, Sophie North, et al.
Biochemical and Biophysical Research Communications|August 30, 2005
WITHDRAWN: Expression of p53, p63, and p73 isoforms in squamous cell carcinoma and adenocarcinoma of esophagus☆,☆☆Rutao Cui, Jinchun He, Rubing Mei, et al.
Annals of Hepatology|November 27, 2008
Detection of p53 codon 249 mutation in Nigerian patients with hepatocellular carcinoma using a novel evaluation of cell-free DNARufina Igetei, Jesse A Otegbayo, Dennis A Ndububa, et al.
BMC Research Notes|November 2, 2011
TP53 mutations, human papilloma virus DNA and inflammation markers in esophageal squamous cell carcinoma from the Rift Valley, a high-incidence area in KenyaKirtika Patel, Simeon Mining, Johnston Wakhisi, et al.
International Journal of Cancer|February 4, 2010
Intraepithelial p63-dependent expression of distinct components of cell adhesion complexes in normal esophageal mucosa and squamous cell carcinomaAmélie Thépot, Agnès Hautefeuille, Marie-Pierre Cros, et al.
Pageof 28

Showing results (101-110 of 280) with videos related to

Sort By:
Pageof 28
The Journal of Gene Medicine|March 9, 2005
Poor intercellular transport and absence of enhanced antiproliferative activity after non-viral gene transfer of VP22-P53 or P53-VP22 fusions into p53 null cell lines in vitro or in vivoDavid Zavaglia, Erh-Hsuan Lin, Mélanie Guidetti, et al.
IARC Scientific Publications|September 25, 2012
Future perspectives on molecular epidemiologyMartyn T Smith, Pierre Hainaut, Frederica Perera, et al.
Mutation Research|May 10, 2005
TP53 mutations as biomarkers for cancer epidemiology in Latin America: current knowledge and perspectivesClaudia Vitória de Moura Gallo, Gulnar Azevedo E Silva Mendonça, Emanuela de Moraes, et al.
Orphanet Journal of Rare Diseases|April 30, 2014
The profile and contribution of rare germline copy number variants to cancer risk in Li-Fraumeni patients negative for TP53 mutationsAmanda G Silva, Ana C V Krepischi, Peter L Pearson, et al.
Cancer Research|May 23, 2002
Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation: evidence for a precursor lesionGiulia Fulci, Nobuaki Ishii, Daniela Maurici, et al.
Oncogene|October 3, 2002
DeltaN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53Stéphanie Courtois, Gerald Verhaegh, Sophie North, et al.
Biochemical and Biophysical Research Communications|August 30, 2005
WITHDRAWN: Expression of p53, p63, and p73 isoforms in squamous cell carcinoma and adenocarcinoma of esophagus☆,☆☆Rutao Cui, Jinchun He, Rubing Mei, et al.
Annals of Hepatology|November 27, 2008
Detection of p53 codon 249 mutation in Nigerian patients with hepatocellular carcinoma using a novel evaluation of cell-free DNARufina Igetei, Jesse A Otegbayo, Dennis A Ndububa, et al.
BMC Research Notes|November 2, 2011
TP53 mutations, human papilloma virus DNA and inflammation markers in esophageal squamous cell carcinoma from the Rift Valley, a high-incidence area in KenyaKirtika Patel, Simeon Mining, Johnston Wakhisi, et al.
International Journal of Cancer|February 4, 2010
Intraepithelial p63-dependent expression of distinct components of cell adhesion complexes in normal esophageal mucosa and squamous cell carcinomaAmélie Thépot, Agnès Hautefeuille, Marie-Pierre Cros, et al.
Pageof 28